Schrenk, Karin G.
297  Ergebnisse:
Personensuche X
?
4

Exceptional response to neoadjuvant targeted therapy with t..:

Schrenk, Karin G. ; Weschenfelder, Wolfram ; Spiegel, Christian...
Journal of Cancer Research and Clinical Oncology.  149 (2022)  9 - p. 5493-5496 , 2022
 
?
6

Outcome of FLT3-ITD-positive acute myeloid leukemia: impact..:

Fleischmann, Maximilian ; Schnetzke, Ulf ; Schrenk, Karin G....
Journal of Cancer Research and Clinical Oncology.  143 (2016)  2 - p. 337-345 , 2016
 
?
9

Detection of Enterococcus spp. in bronchoalveolar lavage fl..:

Desole, Max ; Schrenk, Karin G. ; Schnetzke, Ulf..
Journal of Cancer Research and Clinical Oncology.  142 (2015)  5 - p. 1133-1136 , 2015
 
?
10

Efficacy of antifungal prophylaxis with oral suspension pos..:

Schrenk, Karin G. ; Schnetzke, Ulf ; Stegemann, Katy...
Journal of Cancer Research and Clinical Oncology.  141 (2015)  9 - p. 1661-1668 , 2015
 
?
13

Impact of induction chemotherapy with intermediate-dosed cy..:

Fleischmann, Maximilian ; Schnetzke, Ulf ; Frietsch, Jochen J....
Journal of Cancer Research and Clinical Oncology.  148 (2021)  6 - p. 1481-1492 , 2021
 
?
14

Outcome of patients with relapsed or refractory acute myelo..:

Mühleck, Regina ; Scholl, Sebastian ; Hilgendorf, Inken...
Journal of Cancer Research and Clinical Oncology.  148 (2021)  9 - p. 2539-2548 , 2021
 
?
15

Outcome of patients with relapsed or refractory acute myelo..:

Mühleck, Regina ; Scholl, Sebastian ; Hilgendorf, Inken...
Journal of Cancer Research and Clinical Oncology -- 0171-5216 -- 1432-1335.  , 2022
 
1-15